Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.93
-$0.03-2.75%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.83M | 117.29M | 114.79M | 90.01M | 76.83M |
| Total Depreciation and Amortization | 20.19M | 18.95M | 19.50M | 15.58M | 14.43M |
| Total Amortization of Deferred Charges | 596.60K | 596.60K | 596.60K | 885.70K | 885.70K |
| Total Other Non-Cash Items | 47.46M | 49.23M | 58.28M | 73.09M | 50.26M |
| Change in Net Operating Assets | -6.93M | -28.12M | -35.28M | -38.93M | -40.38M |
| Cash from Operations | 160.15M | 157.94M | 157.88M | 140.64M | 102.03M |
| Capital Expenditure | -20.16M | -16.65M | -14.17M | -9.51M | -10.29M |
| Sale of Property, Plant, and Equipment | 717.90K | 762.00K | 809.30K | 742.80K | 636.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.34M | -25.22M | -25.83M | -46.96M | -12.15M |
| Cash from Investing | -41.78M | -41.11M | -39.19M | -55.73M | -21.80M |
| Total Debt Issued | 5.24B | 4.63B | 4.28B | 4.38B | 4.05B |
| Total Debt Repaid | -4.52B | -4.16B | -4.24B | -4.34B | -4.01B |
| Issuance of Common Stock | 1.68B | 1.68B | 1.68B | 1.78B | 1.83B |
| Repurchase of Common Stock | -1.72B | -1.72B | -1.70B | -1.89B | -1.89B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -29.04M | -41.13M | -42.86M | -44.72M | -45.73M |
| Other Financing Activities | -862.12M | -852.59M | -825.94M | -790.55M | -787.81M |
| Cash from Financing | -38.61M | -63.28M | -85.96M | -93.83M | -92.62M |
| Foreign Exchange rate Adjustments | -3.38M | 4.71M | 4.86M | 9.71M | 4.79M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.38M | 58.26M | 37.58M | 789.10K | -7.60M |